Page last updated: 2024-09-03

cyclo(7-aminoheptanoylphenylalanyl-tryptophyl-lysyl-benzylthreonyl) and Parkinson Disease

cyclo(7-aminoheptanoylphenylalanyl-tryptophyl-lysyl-benzylthreonyl) has been researched along with Parkinson Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ionov, ID; Pushinskaya, II1

Other Studies

1 other study(ies) available for cyclo(7-aminoheptanoylphenylalanyl-tryptophyl-lysyl-benzylthreonyl) and Parkinson Disease

ArticleYear
Somatostatin antagonist induces catalepsy in the aged rat.
    Psychopharmacology, 2013, Volume: 227, Issue:2

    Topics: Age Factors; Aging; Animals; Brain; Catalepsy; Dose-Response Relationship, Drug; Haloperidol; Injections, Intraventricular; Male; Octreotide; Parkinson Disease; Peptides, Cyclic; Rats; Rats, Wistar

2013